Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |